VIASURE Viral Particles
VIASURE Viral Influenza A (H1N1) Positive Control Kit
VIASURE Influenza A (H1N1) positive control kit is based on RNA particles from Influenza A virus.
This control is intended for monitoring the whole process, from nucleic acid extraction to amplification with all nucleic acid detection assays designed for Influenza A (H1NI) identification.

Description
VIASURE Viral Influenza A (H1N1) Positive Control Kit is intended for monitoring the whole reverse transcription quantitative real-time PCR (RT-qPCR) process, from nucleic acid extraction to reverse transcription and amplification steps.
VIASURE Viral Influenza A (H1N1) Positive Control Kit contains non-replicative and non-infectious Influenza A viral particles that are expected to be processed along with respiratory samples from individuals with clinical suspicion of Influenza A infection.
This Kit is intended for use by qualified and trained clinical laboratory personnel specifically instructed and trained in molecular techniques and in vitro diagnostic procedures.
Specifications
Inactivated viral particles. Non infectious & Non replicative
Lyophilized presentation: transport and store at room temperature.
Monodose format for nucleic acid detection techniques.
Final concentration range quantified by digital PCR: 11.000-110.000 copies per vial.
It contains the complete genome of the virus, the RNA sequence is homologous to the isolate A/Arkansas/08/2020, belonging to an Influenza A subtype H1N1 lineage pdm09 (GenBank accession numbers MW130270-77).